Cargando…

Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study

OBJECTIVES: Current recommendations regarding enhanced recovery programs (ERPs) after complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are based on a low level of evidence. The aim of this study is to evaluate the effect of implementing an adapted ERP for C...

Descripción completa

Detalles Bibliográficos
Autores principales: Charleux-Muller, Diane, Fabacher, Thibaut, Romain, Benoit, Meyer, Nicolas, Brigand, Cécile, Delhorme, Jean-Baptiste
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067553/
https://www.ncbi.nlm.nih.gov/pubmed/37020473
http://dx.doi.org/10.1515/pp-2022-0133
_version_ 1785018496758841344
author Charleux-Muller, Diane
Fabacher, Thibaut
Romain, Benoit
Meyer, Nicolas
Brigand, Cécile
Delhorme, Jean-Baptiste
author_facet Charleux-Muller, Diane
Fabacher, Thibaut
Romain, Benoit
Meyer, Nicolas
Brigand, Cécile
Delhorme, Jean-Baptiste
author_sort Charleux-Muller, Diane
collection PubMed
description OBJECTIVES: Current recommendations regarding enhanced recovery programs (ERPs) after complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are based on a low level of evidence. The aim of this study is to evaluate the effect of implementing an adapted ERP for CCRS and HIPEC in a referral center. METHODS: We conducted a study with a prospective group of 44 patients (post-ERP group) who underwent CCRS with HIPEC between July 2016 and June 2018, the period during which ERP was implemented. This group was compared to a second retrospective group of 21 patients who underwent CCRS with HIPEC between June 2015 and June 2016, during which ERP was not yet implemented (pre-ERP group). RESULTS: The ERP compliance rate was 65% in the post-ERP group. The hospital length of stay (HLS) was shorter in the post-ERP group: 24.9 days (IQR 11–68, pre-ERP group) vs. 16.1 days (IQR 6–45, post-ERP group), as was the major morbidity rate (pre-ERP group=33.3% vs. post-ERP group=20.5%). The nasogastric tube, urinary catheter and abdominal drains were all retrieved faster in the post-ERP group. CONCLUSIONS: The implementation of an adapted ERP after CCRS with HIPEC procedures reduces morbidity and shortens the HLS.
format Online
Article
Text
id pubmed-10067553
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-100675532023-04-04 Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study Charleux-Muller, Diane Fabacher, Thibaut Romain, Benoit Meyer, Nicolas Brigand, Cécile Delhorme, Jean-Baptiste Pleura Peritoneum Article OBJECTIVES: Current recommendations regarding enhanced recovery programs (ERPs) after complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are based on a low level of evidence. The aim of this study is to evaluate the effect of implementing an adapted ERP for CCRS and HIPEC in a referral center. METHODS: We conducted a study with a prospective group of 44 patients (post-ERP group) who underwent CCRS with HIPEC between July 2016 and June 2018, the period during which ERP was implemented. This group was compared to a second retrospective group of 21 patients who underwent CCRS with HIPEC between June 2015 and June 2016, during which ERP was not yet implemented (pre-ERP group). RESULTS: The ERP compliance rate was 65% in the post-ERP group. The hospital length of stay (HLS) was shorter in the post-ERP group: 24.9 days (IQR 11–68, pre-ERP group) vs. 16.1 days (IQR 6–45, post-ERP group), as was the major morbidity rate (pre-ERP group=33.3% vs. post-ERP group=20.5%). The nasogastric tube, urinary catheter and abdominal drains were all retrieved faster in the post-ERP group. CONCLUSIONS: The implementation of an adapted ERP after CCRS with HIPEC procedures reduces morbidity and shortens the HLS. De Gruyter 2023-01-11 /pmc/articles/PMC10067553/ /pubmed/37020473 http://dx.doi.org/10.1515/pp-2022-0133 Text en © 2022 the author(s), published by De Gruyter, Berlin/Boston https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License.
spellingShingle Article
Charleux-Muller, Diane
Fabacher, Thibaut
Romain, Benoit
Meyer, Nicolas
Brigand, Cécile
Delhorme, Jean-Baptiste
Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study
title Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study
title_full Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study
title_fullStr Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study
title_full_unstemmed Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study
title_short Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study
title_sort implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067553/
https://www.ncbi.nlm.nih.gov/pubmed/37020473
http://dx.doi.org/10.1515/pp-2022-0133
work_keys_str_mv AT charleuxmullerdiane implementationofanenhancedrecoveryprogramforcompletecytoreductivesurgeryandhyperthermicintraperitonealchemotherapyinareferralcenteracasecontrolprospectivestudy
AT fabacherthibaut implementationofanenhancedrecoveryprogramforcompletecytoreductivesurgeryandhyperthermicintraperitonealchemotherapyinareferralcenteracasecontrolprospectivestudy
AT romainbenoit implementationofanenhancedrecoveryprogramforcompletecytoreductivesurgeryandhyperthermicintraperitonealchemotherapyinareferralcenteracasecontrolprospectivestudy
AT meyernicolas implementationofanenhancedrecoveryprogramforcompletecytoreductivesurgeryandhyperthermicintraperitonealchemotherapyinareferralcenteracasecontrolprospectivestudy
AT brigandcecile implementationofanenhancedrecoveryprogramforcompletecytoreductivesurgeryandhyperthermicintraperitonealchemotherapyinareferralcenteracasecontrolprospectivestudy
AT delhormejeanbaptiste implementationofanenhancedrecoveryprogramforcompletecytoreductivesurgeryandhyperthermicintraperitonealchemotherapyinareferralcenteracasecontrolprospectivestudy